{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:46:23Z","timestamp":1759563983796},"reference-count":50,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Heparin may have beneficial effects on placental health beyond anticoagulation. Thrombin receptor activation on maternal platelets is implicated in placental developmental failure independent of thrombosis.<\/jats:p>","DOI":"10.1182\/blood-2012-08-448209","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T05:22:12Z","timestamp":1358400132000},"page":"2127-2134","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Heparin rescues factor V Leiden\u2013associated placental failure independent of anticoagulation in a murine high-risk pregnancy model"],"prefix":"10.1182","volume":"121","author":[{"given":"Jianzhong","family":"An","sequence":"first","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magarya S.","family":"Waitara","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Bordas","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhyalakshmi","family":"Arumugam","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond G.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Petrich","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego, CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Sinha","sequence":"additional","affiliation":[{"name":"Portola Pharmaceuticals Inc, South San Francisco, CA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula E.","family":"North","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology, and"},{"name":"Children\u2019s Research Institute, and"},{"name":"Children\u2019s Hospital of Wisconsin, Children\u2019s Hospital and Health System, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Sood","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology, and"},{"name":"Children\u2019s Research Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"9","key":"2019111808502618600_B1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2471\/BLT.05.027300","article-title":"Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries.","volume":"84","author":"Ngoc","year":"2006","journal-title":"Bull World Health Organ"},{"issue":"5","key":"2019111808502618600_B2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/03014460902980295","article-title":"Growth and chronic disease: findings in the Helsinki Birth Cohort.","volume":"36","author":"Barker","year":"2009","journal-title":"Ann Hum Biol"},{"key":"2019111808502618600_B3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.2010.05674.x","article-title":"Coagulation disorders in pregnancy: acquired and inherited thrombophilias.","volume":"1205","author":"Benedetto","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2019111808502618600_B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review.","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111808502618600_B5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111808502618600_B6","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111808502618600_B7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.","volume":"10","author":"de Vries","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2019111808502618600_B8"},{"issue":"2","key":"2019111808502618600_B9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1538-7836.2005.01155.x","article-title":"Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?","volume":"3","author":"Lindqvist","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111808502618600_B10"},{"issue":"4","key":"2019111808502618600_B11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1538-7836.2005.01286.x","article-title":"The use of LMWH in pregnancies at risk: new evidence or perception?","volume":"3","author":"Walker","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111808502618600_B12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/plac.2001.0785","article-title":"Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia.","volume":"23","author":"Sikkema","year":"2002","journal-title":"Placenta"},{"issue":"4","key":"2019111808502618600_B13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.0001-6349.2004.00388.x","article-title":"Thrombophilia is not associated with an increase in placental abnormalities in women with intra-uterine fetal death.","volume":"83","author":"Morssink","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"2019111808502618600_B14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2350\/09-05-0657-OA.1","article-title":"Avascular villi, increased syncytial knots, and hypervascular villi are associated with pregnancies complicated by factor V Leiden mutation.","volume":"13","author":"Rogers","year":"2010","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"2019111808502618600_B15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1055\/s-2007-985756","article-title":"Do thrombophilias cause placenta-mediated pregnancy complications?","volume":"33","author":"Rodger","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"2019111808502618600_B16","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0049-3848(09)70022-2","article-title":"Thrombophilia and pregnancy loss: cause or association.","volume":"123","author":"Gris","year":"2009","journal-title":"Thromb Res"},{"issue":"18","key":"2019111808502618600_B17","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2011-07-319749","article-title":"Is heparin a placental anticoagulant in high-risk pregnancies?","volume":"118","author":"Kingdom","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111808502618600_B18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/plac.2001.0738","article-title":"Comparative developmental anatomy of the murine and human definitive placentae.","volume":"23","author":"Georgiades","year":"2002","journal-title":"Placenta"},{"issue":"8","key":"2019111808502618600_B19","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2005-10-4111","article-title":"Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.","volume":"107","author":"Sood","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111808502618600_B20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20062566","article-title":"Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.","volume":"204","author":"Sood","year":"2007","journal-title":"J Exp Med"},{"issue":"43","key":"2019111808502618600_B21","doi-asserted-by":"crossref","first-page":"18605","DOI":"10.1073\/pnas.1013309107","article-title":"Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis.","volume":"107","author":"Cornelissen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111808502618600_B22","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1172\/JCI31024","article-title":"The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.","volume":"117","author":"Petrich","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111808502618600_B23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(00)00219-3","article-title":"Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.","volume":"395","author":"Sinha","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2019111808502618600_B24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.ATV.0000046238.23903.FC","article-title":"The dynamics of thrombin formation.","volume":"23","author":"Mann","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2019111808502618600_B25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1046\/j.1538-7836.2003.00254.x","article-title":"Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex.","volume":"1","author":"Brufatto","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"44","key":"2019111808502618600_B26","doi-asserted-by":"crossref","first-page":"14582","DOI":"10.1021\/bi990958a","article-title":"Inhibition of factor Xa by a peptidyl-alpha-ketothiazole involves two steps. Evidence for a stabilizing conformational change.","volume":"38","author":"Betz","year":"1999","journal-title":"Biochemistry"},{"issue":"8","key":"2019111808502618600_B27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/14767050902853117","article-title":"Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.","volume":"22","author":"Erez","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"2019111808502618600_B28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003081-198528010-00004","article-title":"Intrauterine fetal demise and hemostatic failure: the fetal death syndrome.","volume":"28","author":"Romero","year":"1985","journal-title":"Clin Obstet Gynecol"},{"issue":"10","key":"2019111808502618600_B29","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1074\/jbc.275.10.6819","article-title":"Cathepsin G activates protease-activated receptor-4 in human platelets.","volume":"275","author":"Sambrano","year":"2000","journal-title":"J Biol Chem"},{"issue":"43","key":"2019111808502618600_B30","doi-asserted-by":"crossref","first-page":"32095","DOI":"10.1074\/jbc.M513138200","article-title":"Proteinase-activated receptors, targets for kallikrein signaling.","volume":"281","author":"Oikonomopoulou","year":"2006","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111808502618600_B31","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1182\/blood-2011-09-381400","article-title":"In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling.","volume":"119","author":"Nishimura","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111808502618600_B32","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1182\/blood-2005-01-0406","article-title":"Extraembryonic expression of EPCR is essential for embryonic viability.","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111808502618600_B33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm825","article-title":"The thrombomodulin-protein C system is essential for the maintenance of pregnancy.","volume":"9","author":"Isermann","year":"2003","journal-title":"Nat Med"},{"issue":"9","key":"2019111808502618600_B34","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI2006","article-title":"A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.","volume":"101","author":"Weiler-Guettler","year":"1998","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111808502618600_B35","first-page":"462","article-title":"Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge.","volume":"88","author":"Castellino","year":"2002","journal-title":"Thromb Haemost"},{"issue":"11","key":"2019111808502618600_B36","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"issue":"11","key":"2019111808502618600_B37","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111808502618600_B38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI1509","article-title":"Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.","volume":"101","author":"Koenig","year":"1998","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111808502618600_B39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH05-07-0515","article-title":"The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo.","volume":"95","author":"Ludwig","year":"2006","journal-title":"Thromb Haemost"},{"issue":"12","key":"2019111808502618600_B40","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/j.1538-7836.2011.04526.x","article-title":"Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling.","volume":"9","author":"Drewlo","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111808502618600_B41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/AOG.0b013e31821b5384","article-title":"Angiogenic response of placental villi to heparin.","volume":"117","author":"Sobel","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"21","key":"2019111808502618600_B42","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/01.CIR.0000093279.36628.12","article-title":"Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.","volume":"108","author":"Andr\u00e9","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"2019111808502618600_B43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2004-831051","article-title":"Platelet factor 4: an inhibitor of angiogenesis.","volume":"30","author":"Bikfalvi","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2019111808502618600_B44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"issue":"22","key":"2019111808502618600_B45","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1182\/blood-2009-09-242065","article-title":"Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.","volume":"115","author":"Zaslavsky","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111808502618600_B46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial.","volume":"7","author":"Rey","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111808502618600_B47","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial.","volume":"106","author":"Gris","year":"2011","journal-title":"Thromb Haemost"},{"issue":"14","key":"2019111808502618600_B48","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood"},{"issue":"21","key":"2019111808502618600_B49","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"issue":"17","key":"2019111808502618600_B50","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/11\/2127\/1364372\/2127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/11\/2127\/1364372\/2127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T14:56:43Z","timestamp":1574089003000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/11\/2127\/31088\/Heparin-rescues-factor-V-Leidenassociated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,3,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-08-448209","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}